Sponsors
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
Blog
Chairman, GDS International
Sales and the 'Talent Magnet'
A lot is written about being a ‘Talent Magnet’, either as a company, or as President. It’s all good practice – listen, mentor, reward, provide clear goals and career maps. Good practice for the employer, but what about the employee?25 May 2011
White Papers
Focus Area: Drug Discovery
A New Generation of Vaccines
Novartis is making major investments to be able to offer novel influenza vaccines. Europe's second-largest pharmaceutical company, the fourth largest in the world, is building a latest-technology production site, aiming to improve production reliability for a potential pandemic. NGP spoke with Dr. Jörg Reinhardt, CEO of Novartis’ division Vaccines and Diagnostics, about the company’s proprietary cell culture technology.
The Future of Cell Biology
Kevin Daugherty, Director of Marketing for Greiner Bio-One, and Dr. David Kirk, Technical Director of MDS Pharma Services, sit down to discuss molecular and cell biology, improved tissue devices and the biggest potential for cell culture.
Personalized Medicine Grows Up
Dr. Edwin Clark, Director of the Oncology Biomarker Team at Bristol-Myers Squibb, explores the increasingly important role of biomarkers in the pharma drug development toolbox and shares his hopes for the future of personalized medicine.
Cellular Systems Biology applied to cytotoxicity: CellCiphr profiling
Dr. Kate Johnston, VP at Cellumen, describes the principles and a case study detailing their new profiling technology.
Delving Deeper into DNA
Dr. Patrice Milos, Vice President and Chief Scientific Officer of Helicos BioSciences explains her new role, the innovative new technology she works with and her vision for the future of DNA and RNA.
Source: www.ngpharma.com© 2012 GDS Publishing Ltd. All rights reserved.